FDA-proposed OTC label studies test consumer preference, not informed decisions -- CTFA.
This article was originally published in The Tan Sheet
Executive Summary
FDA OTC LABEL STUDIES TEST CONSUMER PREFERENCE, NOT INFORMED DECISIONS, CTFA maintains in June 13 comments to the Office of Management & Budget. Responding to a call for comments by FDA on its proposal to conduct four consumer OTC drug label comprehension studies, the Cosmetic, Toiletry & Fragrance Association asserts that "major parts of the research seem directed at testing consumer preferences...rather than determining whether the new label formats will in fact produce more-informed and appropriate decision-making about the use of OTC products." The "proper goal is not what the consumer prefers, it is what label information and format will best enable the consumer to properly use these products."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning